Humacyte (HUMA) Non-Current Assets (2020 - 2026)
Humacyte (HUMA) reported Non-Current Assets of $45.3 million for Q2 2026, down 48.0% from $87.07 million a year earlier and down 3.5% from the prior quarter.
Humacyte (HUMA) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Humacyte posted Non-Current Assets of $48.57 million, down 46.0% from FY2024.
- Non-Current Assets has a five-year compound annual growth rate of -5.7% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $90.01 million in FY2024 (+100.3%), $44.95 million in FY2023 (-10.3%), $50.09 million in FY2022 (-12.4%) and $57.19 million in FY2021 (-12.3%).
- The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets since Q2 2024.
- Year over year, Non-Current Assets has now declined in each of the last four quarters, with growth averaging 27.7% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q2 2025 (growth of 106.5%); the low point was Q2 2026 (a decline of 48.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $46.96 million (Q1 2026), $48.57 million (Q4 2025) and $50.16 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Humacyte | 97.33 Mn | -101.11 Mn | -825,000.00 | 45.30 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.30 Mn |
| Mar 31, 2026 | 46.96 Mn |
| Dec 31, 2025 | 48.57 Mn |
| Sep 30, 2025 | 50.16 Mn |
| Jun 30, 2025 | 87.07 Mn |
| Mar 31, 2025 | 88.85 Mn |
| Dec 31, 2024 | 90.01 Mn |
| Sep 30, 2024 | 91.76 Mn |
| Jun 30, 2024 | 42.17 Mn |
| Mar 31, 2024 | 43.54 Mn |
| Dec 31, 2023 | 44.95 Mn |
| Sep 30, 2023 | 46.53 Mn |
| Jun 30, 2023 | 47.54 Mn |
| Mar 31, 2023 | 49.12 Mn |
| Dec 31, 2022 | 50.09 Mn |
| Sep 30, 2022 | 51.61 Mn |
| Jun 30, 2022 | 53.34 Mn |
| Mar 31, 2022 | 55.17 Mn |
| Dec 31, 2021 | 57.19 Mn |
| Sep 30, 2021 | 59.18 Mn |
Humacyte Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=HUMA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "HUMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=HUMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();